Rallybio Corp SEC filings RLYB

Rallybio Corp has 308 filings in SEC EDGAR's recent list, going back to May 7, 2018. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change, shareholder vote results, other events). The company's fiscal year ends on December 31.

Rallybio Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 27, 2026 Sep 30, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
10-Q Quarterly report Sep 9, 2021 Jun 30, 2021

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RLYB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
, Emerging growth company
SEC CIK
1739410
Former names
Rallybio Holdings, LLC (until Jun 7, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.